These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3881175

  • 1. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
    Kirkwood JM, Harris JE, Vera R, Sandler S, Fischer DS, Khandekar J, Ernstoff MS, Gordon L, Lutes R, Bonomi P.
    Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
    [Abstract] [Full Text] [Related]

  • 2. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kotake T, Kinouchi T, Saiki S, Kuroda M, Miki T, Kiyohara H, Usami M.
    Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
    [Abstract] [Full Text] [Related]

  • 3. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
    Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM.
    Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
    [Abstract] [Full Text] [Related]

  • 5. Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.
    Krown SE, Burk MW, Kirkwood JM, Kerr D, Morton DL, Oettgen HF.
    Cancer Treat Rep; 1984 May; 68(5):723-6. PubMed ID: 6722830
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
    Vugrin D, Hood L, Taylor W, Laszlo J.
    Cancer Treat Rep; 1985 May; 69(7-8):817-20. PubMed ID: 4016792
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL, Hollis DR, Rosner GL, Trump DL, Shapiro CL, Vogelzang NJ, Schilsky RL.
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [Abstract] [Full Text] [Related]

  • 9. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [Abstract] [Full Text] [Related]

  • 10. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
    Sarna G, Figlin R, Callaghan M.
    J Biol Response Mod; 1983 Feb; 2(4):343-7. PubMed ID: 6315898
    [Abstract] [Full Text] [Related]

  • 11. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 12. Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study.
    Dutcher JP, Fisher RI, Weiss G, Aronson F, Margolin K, Louie A, Mier J, Caliendo G, Sosman JA, Eckardt JR, Ernest ML, Doroshow J, Atkins M.
    Cancer J Sci Am; 1997 Jan; 3(3):157-62. PubMed ID: 9161781
    [Abstract] [Full Text] [Related]

  • 13. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
    Kawamura J, Yamauchi T, Hashimura T, Yoshida O, Kohnami T, Tomoyoshi T, Ogura K, Fukuyama T, Nakagawa K.
    Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J, Malspeis L, Young D, Neidhart J.
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of renal cell carcinoma. 3. Interferon therapy].
    Kobayashi M, Imai K, Kiren H, Nakai K, Saruki K, Umeyama T, Ito Y, Yamanaka H, Makino T, Machida M.
    Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interferon-alpha therapy of renal cancer.
    Neidhart JA, Gagen MM, Young D, Tuttle R, Melink TJ, Ziccarrelli A, Kisner D.
    Cancer Res; 1984 Sep; 44(9):4140-3. PubMed ID: 6378379
    [Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.